The CEOs of at least three pharmaceutical companies — Pfizer (NYSE:PFE), Merck (NYSE:MRK), and Gilead Sciences (NASDAQ:GILD) — are slated to meet with President Trump at the White House next week.
The Pharmaceutical Research and Manufacturers of America (PhRMA), the main pharma
